awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34132872-5913A4EB-1BA6-4A4C-A7C7-93BFD6F5C1FF
Q34132872-5913A4EB-1BA6-4A4C-A7C7-93BFD6F5C1FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34132872-5913A4EB-1BA6-4A4C-A7C7-93BFD6F5C1FF
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial.
P2860
Q34132872-5913A4EB-1BA6-4A4C-A7C7-93BFD6F5C1FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34132872-5913A4EB-1BA6-4A4C-A7C7-93BFD6F5C1FF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
869aa01aadcd0a11d0c882d5146302742b10152e
P2860
Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.